Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Sensors (Basel) ; 24(3)2024 Jan 30.
Artigo em Inglês | MEDLINE | ID: mdl-38339606

RESUMO

In recent years, radar emitter signal recognition has enjoyed a wide range of applications in electronic support measure systems and communication security. More and more deep learning algorithms have been used to improve the recognition accuracy of radar emitter signals. However, complex deep learning algorithms and data preprocessing operations have a huge demand for computing power, which cannot meet the requirements of low power consumption and high real-time processing scenarios. Therefore, many research works have remained in the experimental stage and cannot be actually implemented. To tackle this problem, this paper proposes a resource reuse computing acceleration platform based on field programmable gate arrays (FPGA), and implements a one-dimensional (1D) convolutional neural network (CNN) and long short-term memory (LSTM) neural network (NN) model for radar emitter signal recognition, directly targeting the intermediate frequency (IF) data of radar emitter signal for classification and recognition. The implementation of the 1D-CNN-LSTM neural network on FPGA is realized by multiplexing the same systolic array to accomplish the parallel acceleration of 1D convolution and matrix vector multiplication operations. We implemented our network on Xilinx XCKU040 to evaluate the effectiveness of our proposed solution. Our experiments show that the system can achieve 7.34 giga operations per second (GOPS) data throughput with only 5.022 W power consumption when the radar emitter signal recognition rate is 96.53%, which greatly improves the energy efficiency ratio and real-time performance of the radar emitter recognition system.

2.
Anal Cell Pathol (Amst) ; 2022: 5946670, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35256924

RESUMO

Papillary thyroid cancer (PTC) is a type of epithelial-derived differentiated TC that reportedly accounts for a majority of TCs. Curcumin, a polyphenolic compound and a member of the Zingiberaceae (ginger) family derived from turmeric plants, can exhibit anticancer effects. Herein, we aimed to investigate the effect of curcumin on PTC and elucidate underlying mechanisms. Accordingly, PTC B-CPAP cells were treated with curcumin, in combination with/without long noncoding RNA LINC00691 inhibition, to determine the effect of curcumin and its relationship with LINC00691 in PTC cells. We observed that curcumin treatment decreased B-CPAP cell proliferation and promoted apoptosis. Curcumin inhibited LINC00691 expression in B-CPAP cells. Curcumin administration or si-LINC00691 transfection alone promoted ATP levels, inhibited glucose uptake and lactic acid levels, and inhibited lactate dehydrogenase A and hexokinase 2 protein expression in B-CPAP cells, which were further enhanced by combination treatment. Moreover, curcumin administration or si-LINC00691 transfection alone inhibited p-Akt activity, further suppressed by combination treatment. Akt inhibition promoted apoptosis and suppressed the Warburg effect in B-CPAP cells. In conclusion, our findings indicate that curcumin promotes apoptosis and suppresses proliferation and the Warburg effect by inhibiting LINC00691 in B-CPAP cells. The precise molecular mechanism might be mediated through the Akt signaling pathway, providing a theoretical basis for the treatment of PTC with curcumin.


Assuntos
Curcumina , RNA Longo não Codificante , Neoplasias da Glândula Tireoide , Apoptose/genética , Linhagem Celular Tumoral , Movimento Celular/genética , Proliferação de Células/genética , Curcumina/farmacologia , Regulação Neoplásica da Expressão Gênica , Humanos , RNA Longo não Codificante/genética , RNA Longo não Codificante/metabolismo , Câncer Papilífero da Tireoide/genética , Câncer Papilífero da Tireoide/metabolismo , Neoplasias da Glândula Tireoide/tratamento farmacológico , Neoplasias da Glândula Tireoide/genética , Neoplasias da Glândula Tireoide/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA